Breast Tissue Expanders

Eileen, Actual Sientra Patient

Breast Tissue Expanders

Eileen, Actual Sientra Patient

See State-of-the-Art Breast Tissue Expander Options Designed for Comfort and Compassion

Dermaspan logo

Soft, Refined Design Allows for Gentle and More Comfortable Expansion

  • Soft, pliable shell results in less friction upon insertion
  • Designed without ridges or rings for improved comfort
  • Port location is designed to aid in predictable, consistent expansion
Dermaspan image
Allo X2 Diagram
Allo X 2 logo

Revolutionary Dual-Port Design and Integral Drain Allow for Less Invasive – Non-Surgical – Draining of Serous Fluid

  • Designed to mitigate key risks associated with breast expansion and ultimately reduce reoperation rates
  • Only tissue expander with an integral drain providing direct access to the periproshetic space where fluid can accumulate
  • Allows for diagnostic fluid sampling to enable a faster treatment response
Allo X2 Aspirate Diagram

The unique feature of the AlloX2 provides surgeons easy access to the periprosthetic space without altering any of the other characteristics of a tissue expander. While one does not plan to experience a postoperative complication, a valid question in light of the availability of the AlloX2 is why one would forego utilizing a device that facilitates treatment thereof.

– ARASH MOMENI, MD
Board-certified plastic and reconstructive surgeon | Palo Alto, CA

See AlloX2 Reduce the Financial Risks Associated with Breast Reconstruction

Managing the Risks of Post-Operative Fluid Accumulation

Exclamation Icon

Obesity (BMI >30) and use of an Acellular Dermal Matrix (ADM) have been identified as major risk factors for seroma4

  • ~40% of adult patients in the US are obese5
  • An ADM is used in over 60% of breast reconstruction cases6
Infection Icon

A seroma increases the risk of major infection in breast reconstruction patients

  • Risk of infection is 4x higher in patients who develop a seroma4
  • Risk of expander loss caused by infection is 6.7x higher in patients who develop a seroma4
Woman Icon

Clinically relevant infections with poor salvage rates occurred in nearly 1/5 of seroma patients (18.8%)4

With current standard of care, 78% of infections require explantation4

Re-Operation Costs Can Run Upwards of +$20K,7 Which May Not Be Covered By Insurance if Within 30 Days of Initial Surgery8

ADM (Alloderm) cost
Breast Tissue Expander cost
OR Anesthesia cost
Total Estimated Cost
ADM (Alloderm) cost
Breast Tissue Expander cost
OR Anesthesia cost
Total Estimated Cost

*ADM currently not approved for use in breast surgery. Please refer to product labeling for more information.

sarai-actual-sientra-patient-top
woman standing in profile with head turned to the viewer

See Clinical Results

AlloX2 Improves Salvage Rates & Clinical Outcomes10

Retrospective review of 112 consecutive patients

  • 63 patients (53.6%) Mentor Artoura
  • 49 patients (43.7%) AlloX2
  • 173 breasts with smooth tissue expanders (2016-2017)

AlloX2 Stats:

  • 8% seroma rate
  • All successfully drained in clinic through AlloX2
  • 1 patient’s aspiration tested positive for MRSA which allowed immediate antibiotic intervention and salvage of reconstruction without explant

100% Surgeon Satisfaction Using AlloX211

In a clinical study with 40 primary reconstructive patients, the AlloX2 was deemed successful in treating seromas and should be considered a tool for noninvasive treatment of common complications of tissue expander-based breast reconstruction.

connect with us
Scroll to top